Comparative Physical Stability of 5% and 10% Zingiber officinale Formulations: Organoleptic, pH, Spreadability, and Adhesion Properties Under Cycling Test Conditions
Main Article Content
Page: 1585-1592
Abstract
Ginger (Zingiber officinale) has demonstrated anti-inflammatory and immunomodulatory potential, supporting its development as a topical agent for inflammatory skin diseases such as psoriasis, but its physical stability must first be confirmed to ensure that therapeutic effects can be attributed to the active compound rather than formulation degradation. This study aimed to evaluate and compare the physical stability of 5% (F1) and 10% (F2) ginger extract salves through organoleptic, pH, spreadability, and adhesion testing under cycling test conditions consisting of six cycles of 24 hours at 4 °C followed by 24 hours at 40 °C, with three replicates per formulation assessed at baseline and after each cycle. Data were analyzed using paired t-tests for within-formulation comparisons and independent t-tests for between-formulation comparisons. Both formulations retained their characteristic ginger aroma, brown color, semi-solid consistency, and homogeneity throughout all six cycles. The pH of F1 ranged from 4.31 to 4.33 and F2 remained at 4.48, with no significant change between cycle 0 and cycle 6 (p > 0.05). Spreadability ranged from 4.79–4.84 cm for F1 and 5.20–5.33 cm for F2, while adhesion time was 4.78–4.82 s for F1 and 3.12–3.14 s for F2. The 10% formulation showed significantly higher pH and spreadability and significantly shorter adhesion time than the 5% formulation (all p<0.001), reflecting concentration-dependent rheological behavior. Both formulations demonstrated acceptable physical stability with all parameters within pharmacopoeial limits, supporting their use in subsequent in vivo efficacy studies for psoriasis.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590. DOI: https://doi.org/10.1136/bmj.m1590
Liu T, Li S, Ying S, et al. The IL-23/IL-17 pathway in inflammatory skin diseases: from bench to bedside. Front Immunol. 2020;11:594735. DOI: https://doi.org/10.3389/fimmu.2020.594735
Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol. 2021;157(8):940-6. DOI: https://doi.org/10.1001/jamadermatol.2021.2007
Sylviningrum T, Putranti IO, Sari OP, Arjadi F, Oktavriana T. HLA-Cw6 allele expression is associated with good narrowband ultraviolet B response in Javanese-Indonesian psoriasis subjects. Indones Biomed J. 2021;13(3):324-31. DOI: https://doi.org/10.18585/inabj.v13i3.1494
Nowak-Perlak M, Szpadel K, Jabłońska I, Pizon M, Woźniak M. Promising strategies in plant-derived treatments of psoriasis—update of in vitro, in vivo, and clinical trials studies. Molecules. 2022;27(3):591. DOI: https://doi.org/10.3390/molecules27030591
Ayustaningwarno F, Anjani G, Ayu AM, Fogliano V. A critical review of ginger's (Zingiber officinale) antioxidant, anti-inflammatory, and immunomodulatory activities. Front Nutr. 2024;11:1364836. DOI: https://doi.org/10.3389/fnut.2024.1364836
Bischoff-Kont I, Fürst R. Benefits of ginger and its constituent 6-shogaol in inhibiting inflammatory processes. Pharmaceuticals (Basel). 2021;14(6):571. DOI: https://doi.org/10.3390/ph14060571
Pázmándi K, Szöllősi AG, Fekete T. The "root" causes behind the anti-inflammatory actions of ginger compounds in immune cells. Front Immunol. 2024;15:1400956. DOI: https://doi.org/10.3389/fimmu.2024.1400956
Bugaut H, Aractingi S. Major role of the IL17/23 axis in psoriasis supports the development of new targeted therapies. Front Immunol. 2021;12:621956. DOI: https://doi.org/10.3389/fimmu.2021.621956
Lukic M, Pantelic I, Savic SD. Towards optimal pH of the skin and topical formulations: from the current state of the art to tailored products. Cosmetics. 2021;8(3):69. DOI: https://doi.org/10.3390/cosmetics8030069
Gao Y, Xu T, Wang Y, et al. Pathophysiology and Treatment of Psoriasis: From Clinical Practice to Basic Research. Pharmaceutics. 2025;17(1):56. DOI: https://doi.org/10.3390/pharmaceutics17010056
Oktavriana T, Kariosentono H, Purwanto B, Widyaningsih V. From Leaf to Relief: Basella alba ethanolic extract alleviates psoriasis-like skin inflammation in BALB/c mice. Salud Cienc Tecnol. 2025;5:2246. DOI: https://doi.org/10.56294/saludcyt20252246
Indrati O, Martien R, Rohman A, Nugroho AK. Development of Nanoemulsion-based Hydrogel Containing Andrographolide: Physical Properties and Stability Evaluation. J Pharm Bioallied Sci. 2020;12(Suppl 2):S816-20. DOI: https://doi.org/10.4103/jpbs.JPBS_174_20
Andleeb M, Shoaib Khan HM, Daniyal M. Development, Characterization and Stability Evaluation of Topical Gel Loaded With Ethosomes Containing Achillea millefolium L. Extract. Front Pharmacol. 2021;12:603227. DOI: https://doi.org/10.3389/fphar.2021.603227
Hawkins S, Dasgupta BR, Ananthapadmanabhan KP. Role of pH in skin cleansing. Int J Cosmet Sci. 2021;43(4):474-83. DOI: https://doi.org/10.1111/ics.12721
Kumar P, Das A. Acid mantle: What we need to know. Indian J Dermatol Venereol Leprol. 2023;89(5):729-32. DOI: https://doi.org/10.25259/IJDVL_153_2022